NYSE:XTNT

Xtant Medical Holdings Stock Insider Trading

Healthcare > Medical - Devices

Buy XTNT

*Your capital is at risk

$0.460

-0.0049 (-1.05%)

At Close: Jun 03, 2026

Xtant Medical Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -91.69. In total, the insiders bought 13.66M and sold 35.35M XTNT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-91.69
● Buy	13.66M shares
● Sell	35.35M shares
72% Buy Activity Weak Negative Correlation
Sell Signal Medium Confidence Jun 01, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -91.69. Confidence increased due to high data reliability score of 90.

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Brandt Kevin D Chief Commercial Officer	Officer	140 583 Value: $168.7K
Aug 15, 2023 Buy	Common Stock A-Award	Vizirgianakis Stavros G. Director	Director	217 770 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Vizirgianakis Stavros G. Director	Director	42 345 Value: $50.8K
Aug 15, 2023 Buy	Common Stock A-Award	Mitchell-keller Lori D Director	Director	145 180 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Mitchell-keller Lori D Director	Director	28 230 Value: $33.9K
Aug 15, 2023 Buy	Common Stock A-Award	Mcnamara Robert Director	Director	145 180 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Bakewell John K Director	Director	28 230 Value: $33.9K
Aug 15, 2023 Buy	Common Stock A-Award	Bakewell John K Director	Director	145 180 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Beeson Jonn R. Director	Director	28 230 Value: $33.9K
Aug 15, 2023 Buy	Common Stock A-Award	Beeson Jonn R. Director	Director	145 180 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Mcnamara Robert Director	Director	28 230 Value: $33.9K
Aug 15, 2023 Buy	Common Stock A-Award	Mcnamara Robert Director	Director	145 180 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Mitchell-keller Lori D Director	Director	28 230 Value: $33.9K
Aug 15, 2023 Buy	Common Stock A-Award	Mitchell-keller Lori D Director	Director	145 180 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Vizirgianakis Stavros G. Director	Director	42 345 Value: $50.8K
Aug 15, 2023 Buy	Common Stock A-Award	Vizirgianakis Stavros G. Director	Director	217 770 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Brandt Kevin D Chief Commercial Officer	Officer	140 583 Value: $168.7K
Aug 15, 2023 Sell	Common Stock F-InKind	Brandt Kevin D Chief Commercial Officer	Officer	49 880 Value: $58.9K
Aug 15, 2023 Buy	Common Stock A-Award	Brandt Kevin D Chief Commercial Officer	Officer	120 499 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Browne Sean E President And CEO	CEO / President	203 252 Value: $243.9K
Aug 15, 2023 Buy	Common Stock A-Award	Browne Sean E President And CEO	CEO / President	174 216 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Neils Scott C Chief Financial Officer	C-Suite Officer	135 501 Value: $162.6K
Aug 15, 2023 Sell	Common Stock F-InKind	Neils Scott C Chief Financial Officer	C-Suite Officer	25 246 Value: $29.8K
Aug 15, 2023 Buy	Common Stock A-Award	Neils Scott C Chief Financial Officer	C-Suite Officer	116 144 Value: $0
Aug 15, 2023 Buy	Stock Option (right to buy) A-Award	Schallenberger Mark A. Chief Operations Officer	Officer	135 501 Value: $162.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT XTANT MEDICAL HOLDINGS INC

Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect ...

Read Full Profile Here